Max Robotics — Global Service Robot Directory + US Certification

About

Hitomi Imai is a urological surgeon and researcher whose work focuses on improving quality-of-life outcomes after robot-assisted radical prostatectomy (RARP) for prostate cancer. Her research centers on three key areas: predicting and mitigating postoperative complications, understanding the factors that drive patient satisfaction, and identifying biomarkers of surgical stress that may influence cancer recurrence. Imai’s most-cited study (2021, 4 citations) demonstrated that perioperative surgical stress is associated with biochemical recurrence in patients with positive surgical margins, offering a novel perspective on the interplay between the surgical environment and oncologic outcomes. Her prospective work (2025, 2 citations) identified predictors of prolonged severe urinary incontinence, while another study (2025, 2 citations) tracked longitudinal changes in patient-reported satisfaction, revealing that factors affecting contentment evolve over time. Imai also pinpointed three preoperative markers—high overactive bladder symptom score, dyslipidemia, and non-nerve-sparing surgery—that predict de novo overactive bladder after RARP (2025, 1 citation). Her contributions are especially valuable for clinicians seeking to personalize surgical approaches and postoperative care, ultimately helping patients maintain a better quality of life after prostate cancer treatment.